KERIN MOKAREM: Open Payments
NPI 1912936204 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$164 in 6 payments from 6 companies in 2025. Trend: 2023 $319 · 2024 $167 · 2025 $164
Food & beverage: $164
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $37 |
| Rigel Pharmaceuticals, Inc. | 1 | $35 |
| Incyte Corporation | 1 | $25 |
| Lilly USA, LLC | 1 | $25 |
| ARRAY BIOPHARMA INC | 1 | $23 |
| Genentech USA, Inc. | 1 | $20 |
Products named: FRUZAQLA, TAVALISSE, Jakafi, JAYPIRCA, LORBRENA, Venclexta.
Industry payments across VA — which companies pay providers there.
